Share

Pfizer wins first US trial over Zoloft

St Louis - Pfizer scored a key victory Friday when it was cleared of liability in the first US trial involving claims that its antidepressant Zoloft can cause birth defects in children born to women who take the drug while pregnant.

Plaintiff Kristyn Pesante claimed that Pfizer failed to warn that using Zoloft during pregnancy could cause birth defects and sought damages after her son was born with a rare, serious congenital heart problem.

Following a week-long trial in St. Louis, Missouri, jurors deliberated briefly before clearing Pfizer of liability, according to a Pfizer spokesperson Neha Wadhwa. Pesante had sought both compensatory and punitive damages, accusing Pfizer of downplaying Zoloft's risks in order to boost sales.

Hundreds of lawsuits saying Zoloft can lead to cardiac and other birth defects have been filed in US state and federal courts. While not binding on the other cases, Friday's verdict is "particularly significant" because Pesante's was the first case selected by plaintiffs for trial and featured much of the same medical evidence and theories underpinning other cases across the country, Wadhwa said.

Pesante's 2012 lawsuit said that Pfizer touted Zoloft as a treatment for depression in pregnant women that had a lower risk of side effects than similar drugs. She said she took the drug during her first trimester and was not aware at the time of the risks.

But Pfizer has disputed any scientific link between Zoloft and birth defects and said that its position is supported by individual medical groups including the American Heart Association, American Psychiatric Association and American College of Obstetricians and Gynecologists.

A lawyer for plaintiffs did not immediately return requests for comment.

Approved by the US Food and Drug Administration, Zoloft is part of a widely prescribed group of antidepressants known as selective serotonin reuptake inhibitors, or SSRIs.

In 2010, GlaxoSmithKline Plc paid an undisclosed amount of money to settle some US lawsuits linking another SSRI, Paxil, to birth defects.

The next Zoloft trial is scheduled to take place later this year in state court in Philadelphia.

We live in a world where facts and fiction get blurred
Who we choose to trust can have a profound impact on our lives. Join thousands of devoted South Africans who look to News24 to bring them news they can trust every day. As we celebrate 25 years, become a News24 subscriber as we strive to keep you informed, inspired and empowered.
Join News24 today
heading
description
username
Show Comments ()
Rand - Dollar
18.96
-0.1%
Rand - Pound
23.92
-0.1%
Rand - Euro
20.43
+0.0%
Rand - Aus dollar
12.35
-0.0%
Rand - Yen
0.13
-0.1%
Platinum
908.05
+1.2%
Palladium
1,014.94
+1.3%
Gold
2,232.75
-0.0%
Silver
24.95
-0.1%
Brent Crude
87.00
+1.8%
Top 40
68,346
0.0%
All Share
74,536
0.0%
Resource 10
57,251
0.0%
Industrial 25
103,936
0.0%
Financial 15
16,502
0.0%
All JSE data delayed by at least 15 minutes Iress logo
Company Snapshot
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE
Government tenders

Find public sector tender opportunities in South Africa here.

Government tenders
This portal provides access to information on all tenders made by all public sector organisations in all spheres of government.
Browse tenders